IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.537
NA - Nord America 15.071
AS - Asia 3.808
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 25
OC - Oceania 21
SA - Sud America 17
Totale 34.551
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.000
IE - Irlanda 5.559
SE - Svezia 2.628
DE - Germania 2.454
UA - Ucraina 2.093
CN - Cina 1.355
HK - Hong Kong 1.195
IT - Italia 1.149
FI - Finlandia 1.112
SG - Singapore 870
IN - India 238
GB - Regno Unito 229
CA - Canada 70
EU - Europa 70
IR - Iran 67
FR - Francia 61
CZ - Repubblica Ceca 50
BE - Belgio 49
NL - Olanda 40
RU - Federazione Russa 27
LT - Lituania 19
SY - Repubblica araba siriana 17
TR - Turchia 17
RO - Romania 15
AU - Australia 14
ES - Italia 10
IL - Israele 9
EG - Egitto 8
BG - Bulgaria 7
CO - Colombia 7
JP - Giappone 7
NZ - Nuova Zelanda 7
VN - Vietnam 7
CH - Svizzera 6
ET - Etiopia 5
KR - Corea 5
AL - Albania 4
AT - Austria 4
ZA - Sudafrica 4
BD - Bangladesh 3
BR - Brasile 3
DK - Danimarca 3
MK - Macedonia 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CI - Costa d'Avorio 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
LU - Lussemburgo 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
CD - Congo 1
DZ - Algeria 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 34.551
Salva come PNG Salva come JPEG
Città #
Dublin 5.543
Jacksonville 3.928
Dearborn 1.869
Chandler 1.333
Wilmington 1.277
Hong Kong 1.193
Lawrence 732
Princeton 732
Beijing 581
San Mateo 564
Singapore 528
Andover 379
Piemonte 371
Ashburn 323
Boardman 308
Ann Arbor 301
Woodbridge 198
Houston 168
Hefei 135
Düsseldorf 114
Philadelphia 114
Nanjing 107
Bremen 102
Kunming 96
Norwalk 91
Grafing 80
Helsinki 62
Jinan 52
Fairfield 50
Munich 49
Novara 49
Brussels 44
Guangzhou 42
Brno 41
Seattle 38
Toronto 38
Nanchang 37
Milan 36
Zanjan 28
Rome 27
Turin 26
Falls Church 24
Shenyang 23
Fuzhou 21
Leawood 20
London 20
Sacramento 19
Chengdu 17
Hangzhou 17
Tappahannock 17
Monmouth Junction 16
Wuhan 16
Strasbourg 15
Chongqing 14
Frankfurt am Main 14
Ottawa 14
Santa Clara 14
Baotou 13
Cambridge 13
Berlin 12
Cassano Magnago 12
Hebei 12
Kocaeli 12
Torino 12
Dallas 11
Horia 11
Lappeenranta 11
Marietta 11
Vercelli 11
Palermo 10
Salerno 10
Shaoxing 10
West Jordan 10
Naples 9
Zhengzhou 9
Amsterdam 8
Auburn Hills 8
Augusta 8
Casalecchio Di Reno 8
Gunzenhausen 8
Mumbai 8
Shanghai 8
Winnipeg 8
Los Angeles 7
Sydney 7
Xian 7
Bari 6
Brescia 6
Changsha 6
Colchester 6
Dong Ket 6
Florence 6
Nanning 6
Redwood City 6
San Jose 6
Trieste 6
Addis Ababa 5
Alessandria 5
Ardabil 5
Auckland 5
Totale 22.431
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 146
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 122
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 113
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 112
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 106
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 105
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 102
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 101
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 96
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 93
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 88
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 84
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 84
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 82
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 82
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 81
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 81
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 79
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 79
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 79
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 79
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 77
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 77
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 76
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 76
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 76
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 76
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 75
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 75
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 75
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 75
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 74
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 74
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 74
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 74
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 74
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 74
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group 73
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 73
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 73
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 73
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 72
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 72
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 72
GROWTH- AND DIFFERENTIATION-ASSOCIATED EXPRESSION OF BCL-2 IN B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 72
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 70
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 70
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias. 69
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 69
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 69
Thrombotic Risk In Patients With Primary Immune Thrombocytopenia Is Only Mildly Increased And Explained By Personal And Treatment-Related Risk Factors 69
COMPARISON OF TWO REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION STRATEGIES FOR MINIMAL RESIDUAL DISEASE EVALUATION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION PERFORMANCE 69
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 69
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 68
I RECETTORI DEI FATTORI DI CRESCITA EMOPOIETICI: STRUTTURA E MECCANISMI DI TRASDUZIONE DEL SEGNALE 68
HIGH FREQUENCY OF EBV ASSOCIATION WITH NON-RANDOM ABNORMALITIES OF THE LONG ARM OF THE CHROMOSOME REGION 1q21-25 IN AIDS-RELATED BURKITT'S LYMPHOMA-DERIVED CELL LINES 68
IN VITRO ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES: PHENOTYPIC CHARACTERIZATION, ONCOGENE AND TUMOR SUPPRESSOR GENE LESIONS, AND HETEROGENEITY IN EPSTEIN-BARR VIRUS INFECTION 68
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 68
Outcome of therapy-related myeloid neoplasms treated with azacitidine 68
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma 68
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 68
Genetic determinants of response to warfarin. 68
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 68
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 68
IN VITRO STUDIES PROVIDE EVIDENCE THAT MULTIPLE PARACRINE LOOPS MAY BE OPERATING IN MULTIPLE MYELOMA 67
BIOLOGIC AND MOLECULAR CHARACTERIZATION OF NON-HODGKIN's LYMPHOMA 67
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 67
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 67
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 67
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 67
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 66
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization 66
MOLECULAR PATHOGENESIS OF AIDS-RELATED LYMPHOMAS 66
PATOLOGIA MOLECOLARE 66
AIDS-RELATED NON-HODGKIN LYMPHOMAS. MOLECULAR GENETICS, VIRAL INFECTION, AND CYTOKINE DEREGULATION 66
PVUII RFLP IN THE CYTOVILLIN GENE (VIL2) ON HUMAN CHROMOSOME 6q 66
ROLE OF BONE MARROW STROMAL CELLS IN THE GROWTH OF MULTIPLE MYELOMA 66
POINT MUTATIONS OF THE BCL-6 GENE IN BURKITT's LYMPHOMA 66
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 66
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 66
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 66
-Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 66
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 65
MUTATIONS IN THE CODING REGION OF C-MYC OCCUR FREQUENTLY IN ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED LYMPHOMAS 65
NUCLEOTIDE SEQUENCE, TRANSCRIPTION MAP AND MUTATION ANALYSIS OF THE 13q14 CHROMOSOMAL REGION DELETED IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 65
BCL-6 PROTEIN EXPRESSION IN HUMAN PERIPHERAL T-CELL NEOPLASMS IS RESTRICTED TO CD30+ ANAPLASTIC LARGE CELL LYMPHOMAS 65
EXPRESSION PROFILE OF MUM1/IRF4, BCL-6, AND CD138/SYNDECAN-1 dEFINES NOVEL HISTOGENETIC SUBSETS OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMAS 65
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 65
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 65
Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication 65
Genetic determinants of response to warfarin. 65
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 65
AIDS-RELATED BURKITT's LYMPHOMA. MORPHOLOGIC AND IMMUNOPHENOTYPIC STUDY OF BIOPSY SPECIMENS 65
Targeting p53 in chronic lymphocytic leukemia 65
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 64
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 64
DELETIONS INVOLVING TWO DISTINCT REGIONS OF 6q IN B-CELL NON-HODGKIN LYMPHOMA 64
Totale 7.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.888 0 0 0 0 0 0 1.582 344 769 452 729 12
2020/20214.584 685 32 675 15 640 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.107 241 214 246 76 585 51 630 78 23 41 215 707
2024/20251.547 182 63 257 173 245 477 150 0 0 0 0 0
Totale 35.318